X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Novartis with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs TEVA PHARMA (Israel) - Comparison Results

NOVARTIS    Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   TEVA PHARMA
EQUITY SHARE DATA
    NOVARTIS
Mar-16
TEVA PHARMA
Dec-13
NOVARTIS/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs9822,677-   
Low Rs5562,326-   
Sales per share (Unadj.) Rs252.91,536.5-  
Earnings per share (Unadj.) Rs62.196.0-  
Cash flow per share (Unadj.) Rs63.3220.2-  
Dividends per share (Unadj.) Rs10.0084.02-  
Dividend yield (eoy) %1.33.4 38.7%  
Book value per share (Unadj.) Rs363.61,706.7-  
Shares outstanding (eoy) m31.96848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.01.6 186.8%   
Avg P/E ratio x12.426.1 47.5%  
P/CF ratio (eoy) x12.211.4 107.0%  
Price / Book Value ratio x2.11.5 144.3%  
Dividend payout %16.187.5 18.4%   
Avg Mkt Cap Rs m24,5802,121,238 1.2%   
No. of employees `0000.844.9 1.7%   
Total wages/salary Rs m1,8010-   
Avg. sales/employee Rs Th10,748.928,989.7 37.1%   
Avg. wages/employee Rs Th2,395.20-   
Avg. net profit/employee Rs Th2,641.11,811.0 145.8%   
INCOME DATA
Net Sales Rs m8,0831,302,940 0.6%  
Other income Rs m8290-   
Total revenues Rs m8,9131,302,940 0.7%   
Gross profit Rs m234356,811 0.1%  
Depreciation Rs m37105,318 0.0%   
Interest Rs m225,592 0.0%   
Profit before tax Rs m1,025225,901 0.5%   
Minority Interest Rs m01,026 0.0%   
Prior Period Items Rs m170-   
Extraordinary Inc (Exp) Rs m1,696-148,292 -1.1%   
Tax Rs m752-2,758 -27.3%   
Profit after tax Rs m1,98681,394 2.4%  
Gross profit margin %2.927.4 10.6%  
Effective tax rate %73.4-1.2 -6,008.6%   
Net profit margin %24.66.2 393.3%  
BALANCE SHEET DATA
Current assets Rs m12,678880,001 1.4%   
Current liabilities Rs m2,433767,435 0.3%   
Net working cap to sales %126.78.6 1,467.0%  
Current ratio x5.21.1 454.4%  
Inventory Days Days3391 36.0%  
Debtors Days Days2296 23.4%  
Net fixed assets Rs m69425,569 0.0%   
Share capital Rs m1603,207 5.0%   
"Free" reserves Rs m11,4600-   
Net worth Rs m11,6211,447,319 0.8%   
Long term debt Rs m0666,222 0.0%   
Total assets Rs m14,4002,977,635 0.5%  
Interest coverage x570.59.8 5,805.4%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.4 128.3%   
Return on assets %13.83.6 384.2%  
Return on equity %17.15.6 303.9%  
Return on capital %23.64.9 478.1%  
Exports to sales %0.70-   
Imports to sales %18.60-   
Net fx Rs m-1,6350-   
CASH FLOW
From Operations Rs m2,531207,621 1.2%  
From Investments Rs m-8,270-73,569 11.2%  
From Financial Activity Rs m-386-249,056 0.2%  
Net Cashflow Rs m-6,125-115,003 5.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.14 Rs / USD

Compare NOVARTIS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare NOVARTIS With: DISHMAN PHARMA  ALEMBIC LTD  TTK HEALTHCARE  CADILA HEALTHCARE  GLENMARK PHARMA  



Today's Market

Sensex Plummets 390 Points; Infosys Continues to Fall(01:30 pm)

After opening the day on a negative note, the share markets in India continued to witness selling pressure as Infosys cracked after Vishal Sikka's resignation as MD & CEO.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Aug 18, 2017 03:37 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS